CA2378598A1 - Medicaments comprising relaxin and their use - Google Patents

Medicaments comprising relaxin and their use Download PDF

Info

Publication number
CA2378598A1
CA2378598A1 CA002378598A CA2378598A CA2378598A1 CA 2378598 A1 CA2378598 A1 CA 2378598A1 CA 002378598 A CA002378598 A CA 002378598A CA 2378598 A CA2378598 A CA 2378598A CA 2378598 A1 CA2378598 A1 CA 2378598A1
Authority
CA
Canada
Prior art keywords
relaxin
acceptable carrier
hair growth
pharmaceutically acceptable
androgenetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002378598A
Other languages
English (en)
French (fr)
Inventor
Raziel Lurie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/348,062 external-priority patent/US6075005A/en
Application filed by Individual filed Critical Individual
Publication of CA2378598A1 publication Critical patent/CA2378598A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002378598A 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use Abandoned CA2378598A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/348,062 US6075005A (en) 1993-10-03 1999-07-06 Medicaments comprising relaxin and their use
US09/348,062 1999-07-06
PCT/IB2000/000901 WO2001001997A1 (en) 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use

Publications (1)

Publication Number Publication Date
CA2378598A1 true CA2378598A1 (en) 2001-01-11

Family

ID=23366490

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002378598A Abandoned CA2378598A1 (en) 1999-07-06 2000-07-03 Medicaments comprising relaxin and their use

Country Status (4)

Country Link
EP (1) EP1154783A4 (de)
AU (1) AU771256B2 (de)
CA (1) CA2378598A1 (de)
WO (1) WO2001001997A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3750542A4 (de) * 2018-02-06 2022-01-26 Centro Internacional de Cosmiatría, S.A.P.I. de C.V. Formulierung und verfahren zur behandlung von androgener alopezie

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224780B1 (es) * 2002-02-21 2007-03-01 Adnan Ammura Taha Composicion regeneradora capilar.
US7320967B2 (en) 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
ES2576655B1 (es) * 2015-01-08 2017-04-20 Anastasio SOLANA MURILLO Tratamiento capilar compuesto de acetato de ciproterona

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096246A (en) * 1960-05-24 1963-07-02 Warner Lambert Pharmaceutical Process for the extraction and purification of relaxin
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
FI59534C (fi) * 1979-10-31 1981-09-10 Orion Yhtymae Oy Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
IL107167A (en) * 1993-10-03 2000-01-31 Raziel Lurie Compositions containing relaxin for treatment of alopecia and related conditions
WO1997011702A1 (en) * 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3750542A4 (de) * 2018-02-06 2022-01-26 Centro Internacional de Cosmiatría, S.A.P.I. de C.V. Formulierung und verfahren zur behandlung von androgener alopezie

Also Published As

Publication number Publication date
AU771256B2 (en) 2004-03-18
WO2001001997A1 (en) 2001-01-11
AU5419900A (en) 2001-01-22
EP1154783A4 (de) 2005-01-19
EP1154783A1 (de) 2001-11-21

Similar Documents

Publication Publication Date Title
US6075005A (en) Medicaments comprising relaxin and their use
Shapiro et al. Hair regrowth: therapeutic agents
US5407944A (en) Compositions and methods for promoting hair growth
US20100172865A1 (en) Methods of enhancing hair growth
US20040023867A1 (en) Methods and compositions for treating benign gynecological disorders
CA2705529C (en) C-19 steroids having an androsten-17-(or4)-3-one structure for cosmetic and further uses
US5574011A (en) Compositions and methods for the treatment of male-pattern baldness
DK2500062T3 (en) C-19 steroids to specific therapeutic applications,
Gruber et al. Current concepts in aesthetic endocrinology
JPH11500145A (ja) 毛髪の成長の刺激または促進および／または脱毛を抑制するブラジキニン拮抗薬の使用
AU771256B2 (en) Medicaments comprising relaxin and their use
Faloia et al. Effect of finasteride in idiopathic hirsutism
Mor et al. Cutaneous complications of hormonal replacement therapy
Murray Natural progesterone: what role in women’s health care
SCHRIOCK et al. Treatment of hirsutism
McKenna et al. The adrenal cortex and virilization
US6395706B1 (en) Medicaments comprising relaxin and their use
Neumann Pharmacology and clinical use of antiandrogens: a short review
WO2014073919A1 (ko) 탈모증의 예방, 치료 또는 개선용 조성물
Tromovitch et al. Medical treatment of male pattern alopecia (androgenic alopecia)
Sagili et al. Cutaneous manifestations of estrogen excess and deficiency
HRP20040914A2 (en) Pharmaceutical and cosmetic compositions comprising plgf-1
Sawaya Alopecia-the search for novel agents continues
GB2131292A (en) Progestational pharmaceutical formulations
WO2004012712A1 (en) Methods and compositions for treating benign gynecological disorders, contraception, and hormone replacement

Legal Events

Date Code Title Description
FZDE Dead